Xin Lang Cai Jing·2025-10-31 02:27Core Viewpoint - China Life's performance in the first three quarters of 2025 exceeded expectations, driven by significant gains in equity investment returns and a strong increase in net profit [1][2]. Financial Performance - For the first nine months of 2025, the company's net profit attributable to shareholders increased by 60.5% year-on-year to 167.8 billion yuan, with a corresponding increase of 91.5% year-on-year in Q3 2025 to 126.87 billion yuan [1][2]. - The total investment return rate for the company reached 6.42%, an increase of 1.04 percentage points year-on-year [2]. Business Development Trends - New business value saw a significant increase, with new single premiums rising by 10.4% year-on-year to 218.034 billion yuan, and comparable new business value (NBV) increasing by 41.8% [2]. - The proportion of floating income products in the first-year premium income rose significantly by over 45 percentage points, indicating a rapid transition towards dividend insurance [2]. - The individual insurance sales workforce stabilized, with 607,000 sales personnel in Q3 2025, reflecting a recovery trend compared to earlier in the year [2]. Profit Forecast and Valuation - China Life A/H shares are currently trading at 0.80x/0.41x 2025e P/EV. The earnings forecast for 2025 and 2026 has been raised by 122.4% and 77.9% to 176.12 billion yuan and 140.56 billion yuan, respectively [3]. - The target price for A/H shares has been increased by 21% and 41% to 46.6 yuan and 34.4 HKD, respectively, indicating potential upside of 5.0% and 39.2% from current prices [3].